1. Home
  2. FFIC vs PRME Comparison

FFIC vs PRME Comparison

Compare FFIC & PRME Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

FFIC

Flushing Financial Corporation

HOLD

Current Price

$16.30

Market Cap

563.8M

Sector

Finance

ML Signal

HOLD

Logo Prime Medicine Inc.

PRME

Prime Medicine Inc.

HOLD

Current Price

$4.13

Market Cap

666.1M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
FFIC
PRME
Founded
1929
2019
Country
United States
United States
Employees
N/A
N/A
Industry
Major Banks
Medicinal Chemicals and Botanical Products
Sector
Finance
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
563.8M
666.1M
IPO Year
1996
2022

Fundamental Metrics

Financial Performance
Metric
FFIC
PRME
Price
$16.30
$4.13
Analyst Decision
Hold
Buy
Analyst Count
1
5
Target Price
$16.80
$6.42
AVG Volume (30 Days)
306.6K
2.2M
Earning Date
04-28-2026
01-01-0001
Dividend Yield
5.51%
N/A
EPS Growth
N/A
24.31
EPS
0.43
N/A
Revenue
$6,947,000.00
$2,983,000.00
Revenue This Year
$14.57
$95.64
Revenue Next Year
$6.64
N/A
P/E Ratio
$37.12
N/A
Revenue Growth
N/A
N/A
52 Week Low
$10.65
$1.11
52 Week High
$17.79
$6.94

Technical Indicators

Market Signals
Indicator
FFIC
PRME
Relative Strength Index (RSI) 47.94 59.36
Support Level $14.44 $3.19
Resistance Level $16.99 $4.04
Average True Range (ATR) 0.42 0.23
MACD -0.08 0.06
Stochastic Oscillator 25.00 96.63

Price Performance

Historical Comparison
FFIC
PRME

About FFIC Flushing Financial Corporation

Flushing Financial Corp operates as a bank holding company, which is engaged in the provision of banking and financial services. It provides Personal, Business, lending, Government banking, and Card services. Its principal business is attracting retail deposits from the general public and investing those deposits together with funds generated from ongoing operations and borrowings, in originations and purchases of multi-family residential properties, commercial business loans, commercial real estate mortgage loans, construction loans, small business administration loans, and other small business loans.

About PRME Prime Medicine Inc.

Prime Medicine Inc is a biotechnology company committed to delivering genetic therapies to address diseases by deploying gene editing technology, Prime Editing. The Prime Editing technology is a next-generation technology that can search and replace to restore normal genetic function in the genome and can treat a wide spectrum of diseases with high unmet medical needs and efficient and broad gene editing technology.

Share on Social Networks: